Table 3.
The mean and standard deviation of variables in the study before and after treatment in the group treated with metformin and pioglitazone (second group)
| Variable | MEAN ± SD | P value | |
|---|---|---|---|
| Before treatment | After treatment | ||
| FBS (mg/dl) | 170.26 ± 56.144 | 149.72 ± 46.66 | <0.001 |
| BS2hpp (mg/dl) | 244.00 ± 77.73 | 212.49 ± 66.56 | <0.001 |
| HbA1c (%) | 8.63 ± 0.64 | 7.88 ± 1.20 | <0.001 |
| BUN (mg/dl) | 10.90 ± 3.25 | 10.80 ± 2.67 | 0.54 |
| Creatinin (mg/dl) | 0.95 ± 0.17 | 1.005 ± 0.81 | 0.58 |
| AST (U/L) | 27.81 ± 5.90 | 27.60 ± 6.05 | 0.38 |
| ALT (U/L) | 26.60 ± 6.42 | 26.26 ± 6.80 | 0.231 |
| TG (mg/dl) | 176.74 ± 106.43 | 177.59 ± 86.79 | 0.937 |
| Chol (mg/dl) | 176.49 ± 35.98 | 171.50 ± 37.98 | 0.249 |
| HDL (mg/dl) | 43.95 ± 8.67 | 44.12 ± 8.28 | 0.823 |
| Weight (kg) | 73.01 ± 11.49 | 73.29 ± 11.50 | 0.314 |
| SBP (mmHg) | 121.81 ± 14.39 | 119.09 ± 14.01 | 0.06 |
| DBP (mmHg) | 69.88 ± 7.37 | 69.12 ± 7.78 | 0.397 |